The Cleveland Invalidity Clause

The Cleveland Clinic Foundation

1.) Pregabalin (Lyrica): Pregabalin is FDA-approved for the management of neuropathic pain associated with diabetic peripheral neuropathy, postherpetic neuralgia, and as an adjunct therapy for patients with partial-onset seizures. Although it is a structural analogue of gamma-aminobutyric acid (GABA), its exact mechanism is unknown. Common adverse effects associated with pregabalin use include ...

The aftermath of Cleveland.

The Cleveland Clinic Way

The global healthcare market continues to rapidly evolve, so it is important for all healthcare practitioners to be equally adept in their management of healthcare delivery as in their practice of medicine. A recent book by Toby Cosgrove MD, the CEO and president of the Cleveland Clinic, offers exquisite insight into transforming the institution’s healthcare delivery and outcomes to meet the 21...

The Invalidity of the Argument from Illusion

The argument from illusion attempts to establish the bold claim that we are never perceptually aware of ordinary material objects. The argument has rightly received a great deal critical of scrutiny. But here we develop a criticism which, to our knowledge, has not hitherto been explored. We consider the canonical form of the argument as it is captured in contemporary expositions. There are two ...

NovoSeven: Cleveland Clinic Guidelines

In This Issue: • NovoSeven • Therapeutic Interchanges Introduction: Recombinant human activated Factor VII (rFVIIa), or NovoSeven, is a hemostatic agent which is structurally similar to human plasma-derived coagulation Factor VIIa. Recombinant FVIIa is currently licensed by the US Food and Drug Administration (FDA) in patients with hemophilia A or B with inhibitors to Factor VIII or Factor IX o...